Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.66 | N/A |
| PEG Ratio (TTM) | 7.50 | N/A |
| P/S Ratio (TTM) | 2.41 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 17.76 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.21 | N/A |
| Price to 5YR AVG FCF Ratio | -102.27 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.94% | N/A |
| ROE (TTM) | 8.88% | N/A |
| Net Profit Margin (TTM) | 16.27% | N/A |
| ROIC 5YR AVG | 9.91% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 11.49% | 12.57% | 5.44% |
| Revenue | 14.89% | 5.79% | 5.06% |
| Net Income | 10.76% | 13.78% | 5.50% |
| Cash Flow | 32.51% | -253.59% | -124.15% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.10 | N/A |
| Quick Ratio (TTM) | 0.10 | N/A |
| D/E Ratio (TTM) | 0.86 | N/A |
| Interest Coverage (TTM) | 1.04 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -115.30 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.09% | N/A |